Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Hepatic Elastography-Enhanced Lifestyle Modification in MASLD [NA]
Ongoing clinical trial update shows enrollment by invitation for a hepatic elastography-enhanced lifestyle modification program in MASLD pat…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Sagimet Biosciences completed a Phase 2 study of TVB-2640 in nonalcoholic steatohepatitis (NASH) with results posted in May 2025.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis [Phase 2]
Clinical trial update for a Phase 2 study evaluating three HU6 dose levels versus placebo in nonalcoholic steatohepatitis; the trial status …
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions [NA]
Clinical trial update describing a study that integrates metabolic and vascular sensors to monitor cardiometabolic disorders after nutrition…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: LITMUS Imaging Study
Clinical trial update on the LITMUS Imaging Study evaluating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. The study st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Hepatoprotective Measures for Children at High Risk of NAFLD [Phase 4]
Phase 4 clinical trial update on hepatoprotective measures for children at high risk of nonalcoholic fatty liver disease, including those wh…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
A clinical trial update on a cell-based therapy using C-Kit positive hepatic endothelial cells with MerTK deficiency for nonalcoholic fatty …
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
This clinical trial update reviews the validity of laboratory biomarkers for diagnosing nonalcoholic fatty liver disease. It discusses poten…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD [Phase 2]
Phase 2a clinical trial update evaluating the safety, tolerability, and efficacy of TLC-2716 in adults with hypertriglyceridemia and nonalco…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating whether reducing iron levels could treat diabetes and nonalcoholic fatty liver disease. The study is s…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD
A completed Janssen-sponsored study aims to estimate how common genetic variants associated with non-alcoholic fatty liver disease are in he…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes [NA]
This clinical trial evaluates a polyphenol-rich beverage derived from red grape pomace for its effects on nonalcoholic fatty liver disease, …
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS [NA]
Completed clinical trial assessing an oral amino acid nutrition formulation to improve glucose excursions in Polycystic Ovary Syndrome, with…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Longitudinal Observational Study Of Chinese With NAFLD/NASH
A longitudinal observational study enrolling Chinese participants with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis is c…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
This is an ongoing clinical trial follow-up study investigating Chronic hepatitis B patients with comorbid Nonalcoholic fatty liver disease,…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) [Phase 2]
Pfizer completed a Phase 2 trial (MIRNA) evaluating metabolic interventions for nonalcoholic steatohepatitis with liver fibrosis. Results ha…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD [Phase 4]
Phase 4 clinical trial investigating the effect of erugliflozin on liver fat, liver fibrosis, and glycemic control in patients with type 2 d…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease [NA]
This ClinicalTrials.gov entry describes a study aimed at optimizing noninvasive assessment of dysmetabolic compensated advanced liver diseas…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
This clinical trial update notes ongoing recruitment for a study evaluating quantitative ultrasound methods to diagnose nonalcoholic steatoh…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
This clinical trial update describes a study on digital prevention strategies for nonalcoholic fatty liver disease and nonalcoholic steatohe…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Effects of Compound Probiotics-Polygonatum Sibiricum on Liver Health and Metabolism in Middle-aged and Elderly People [NA]
A clinical trial update describing a study of Compound Probiotics-Polygonatum Sibiricum to assess its effects on liver health and metabolism…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Conditionally Increased Output (CIO) Enhanced Ultrasound System [NA]
The clinical trial update reports the completion of the CIO Enhanced Ultrasound System study conducted at Massachusetts General Hospital, in…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Benefit of a Hospital Intervention in Patients With Hepatic Steatosis [NA]
This clinical trial aims to evaluate a hospital intervention for patients with hepatic steatosis and is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 4]
A Phase 4 clinical trial evaluating the SGLT2 inhibitor dapagliflozin in adults with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver D…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Cardiac Dysfunction in Patients with Fatty Liver Disease
A recruiting clinical trial sponsored by the Post Graduate Institute of Medical Education and Research in Chandigarh evaluating cardiac dysf…